80% of people will become infected with Human Papillomavirus (HPV) at some point in their lives. While often harmless, it can, in some cases, lead to serious illnesses such as cervical cancer. However, a new study from the United States offers hope: Deaths from cervical cancer have decreased by as much as 62%—thanks to the vaccine.
HPV is a virus that often causes no symptoms but can, in severe cases, progress to cervical cancer. The fight against the disease began in 2006/2007 with the introduction of the first vaccines, which were less effective than today’s versions. Current vaccines protect against 90% of known HPV variants. They are most effective when administered before the first sexual contact—the earlier, the better. However, even for those vaccinated at the age of 25, the risk of an HPV infection is still reduced by 50%. A recent U.S. study revealed that since the vaccine’s introduction, cervical cancer deaths have significantly declined.
62% Fewer Deaths: HPV Vaccine Saves Lives According to New Study
The Medical University of South Carolina has discovered that cervical cancer mortality decreased by 62% over the last 19 years. Between 1992 and 1994, 55 out of every 100,000 people died from the disease. This number dropped to 35 per 100,000 between 2013 and 2015, and further declined to just 13 per 100,000 between 2019 and 2021. This remarkable decline is attributed to improved vaccines, higher vaccination rates, and the vaccine’s long-term effects. These findings suggest that women are now largely protected against cervical cancer.
More Countries Are Providing HPV Vaccination Each Year
Are you not vaccinated yet? There’s good news: Every year, more countries are including HPV vaccination in their national vaccination schedules. Some even offer it for free. The vaccine requires two to three doses to ensure full protection. Studies like the recent one from the U.S. demonstrate its effectiveness: With an 80% vaccination rate, achieving “herd immunity” is possible. If enough people are vaccinated, the virus could eventually be eradicated.
The rights to the content remain with the original publisher.
